Investor Presentation January 2022 slide image

Investor Presentation January 2022

CooperSurgical Healthy women, babies and familiesTM 5 FY21 Revenue $771M Revenue by Category Fertility 41% Office & surgical products Paragard intrauterine copper contraceptive endosee ADVANCE Cooper Companies 59% Cooper Surgical INSORB Skin Stapler Absorbable | Subcuticular 15
View entire presentation